ANAVEX LIFE SCIENCES CORP. Quarterly Common Stock, Shares, Issued from Q3 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Anavex Life Sciences Corp. quarterly Common Stock, Shares, Issued history and growth rate from Q3 2010 to Q2 2024.
  • Anavex Life Sciences Corp. Common Stock, Shares, Issued for the quarter ending June 30, 2024 was 84.8M shares, a 4.18% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 84.8M +3.4M +4.18% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 83.6M +3.38M +4.21% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 82.1M +4.05M +5.2% Dec 31, 2023 10-Q 2024-02-07
Q3 2023 82.1M +4.12M +5.29% Sep 30, 2023 10-Q 2024-08-06
Q2 2023 81.4M +3.45M +4.42% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 80.2M +3.07M +3.98% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 78M +1.88M +2.47% Dec 31, 2022 10-Q 2023-02-07
Q3 2022 77.9M +2.02M +2.67% Sep 30, 2022 10-K 2023-11-27
Q2 2022 77.9M +2.79M +3.72% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 77.2M +7.13M +10.2% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 76.2M +9.19M +13.7% Dec 31, 2021 10-Q 2022-02-09
Q3 2021 75.9M +13.9M +22.4% Sep 30, 2021 10-K 2022-11-28
Q2 2021 75.1M +15.1M +25.1% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 70M +11.4M +19.4% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 67M +9.88M +17.3% Dec 31, 2020 10-Q 2021-02-16
Q3 2020 62M +9.39M +17.8% Sep 30, 2020 10-K 2021-11-24
Q2 2020 60.1M +8.57M +16.6% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 58.7M +10.5M +21.8% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 57.1M +10.2M +21.7% Dec 31, 2019 10-Q 2020-02-06
Q3 2019 52.7M +6.72M +14.6% Sep 30, 2019 10-K 2020-12-28
Q2 2019 51.5M +6.2M +13.7% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 48.2M +3.6M +8.08% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 46.9M +2.47M +5.55% Dec 31, 2018 10-Q 2019-02-07
Q3 2018 45.9M +2.6M +6.01% Sep 30, 2018 10-K 2019-12-16
Q2 2018 45.3M +3.14M +7.45% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 44.6M +3.2M +7.73% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 44.4M +3.75M +9.23% Dec 31, 2017 10-Q 2018-02-07
Q3 2017 43.3M +7.16M +19.8% Sep 30, 2017 10-K/A 2019-01-25
Q2 2017 42.2M +6.46M +18.1% Jun 30, 2017 10-Q 2017-08-07
Q1 2017 41.4M +5.68M +15.9% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 40.7M +6.01M +17.4% Dec 31, 2016 10-Q 2017-02-07
Q3 2016 36.2M +4.12M +12.9% Sep 30, 2016 10-K 2017-12-11
Q2 2016 35.7M -50.5M -58.6% Jun 30, 2016 10-Q 2016-08-11
Q1 2016 35.7M -29.2M -45% Mar 31, 2016 10-Q 2016-05-11
Q4 2015 34.7M -20.2M -36.8% Dec 31, 2015 10-Q 2016-02-08
Q3 2015 32M +20.2M +172% Sep 30, 2015 10-K 2016-12-14
Q2 2015 86.2M +48M +125% Jun 30, 2015 10-Q 2015-08-14
Q1 2015 64.9M +26.6M +69.6% Mar 31, 2015 10-Q 2015-05-14
Q4 2014 54.8M +17.2M +45.6% Dec 31, 2014 10-Q 2015-02-17
Q3 2014 11.8M -25.4M -68.3% Sep 30, 2014 10-K 2015-12-29
Q2 2014 38.3M +8.02M +26.5% Jun 30, 2014 10-Q 2014-08-13
Q1 2014 38.3M +8.02M +26.5% Mar 31, 2014 10-Q/A 2014-05-30
Q4 2013 37.6M +7.4M +24.5% Dec 31, 2013 10-Q 2014-02-14
Q3 2013 37.2M +7M +23.1% Sep 30, 2013 10-K 2014-12-29
Q2 2013 30.2M +75K +0.25% Jun 30, 2013 10-Q 2013-08-14
Q1 2013 30.2M +2.78M +10.1% Mar 31, 2013 10-Q 2013-05-17
Q4 2012 30.2M +3.05M +11.2% Dec 31, 2012 10-Q 2013-02-14
Q3 2012 30.2M +3.67M +13.8% Sep 30, 2012 10-K 2013-12-30
Q2 2012 30.2M +4.24M +16.4% Jun 30, 2012 10-Q 2012-08-17
Q1 2012 27.5M Mar 31, 2012 10-Q 2012-05-15
Q4 2011 27.2M Dec 31, 2011 10-Q 2012-02-14
Q3 2011 26.6M +3.05M +13% Sep 30, 2011 10-K 2012-12-31
Q2 2011 25.9M Jun 30, 2011 10-Q 2011-08-12
Q3 2010 23.5M Sep 30, 2010 10-K 2011-12-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.